Marinus Pharmaceuticals reported 3.53M in Trade Debtors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 61.67M 9.85M
Adamas Pharmaceuticals ADMS:US 10.05M 57K
Amgen AMGN:US $ 4765M 286M
Aptinyx Inc APTX:US $ 0 0
Biogen BIIB:US $ 2123M 12.8M
Eisai 4523:JP Y 174606M 61730M
Esperion Therapeutics ESPR:US 21.71M 144K
Gilead Sciences GILD:US $ 4566M 417M
Intra Cellular Therapies ITCI:US $ 16.93M 1.75M
Marinus Pharmaceuticals MRNS:US 3.53M 669K
Neurocrine Biosciences NBIX:US $ 163.8M 5.3M
Ptc Therapeutics PTCT:US $ 96.64M 17.84M
Regeneron Pharmaceuticals REGN:US $ 5452M 1546.6M
Sarepta Therapeutics SRPT:US $ 181.56M 33.29M
Supernus Pharmaceuticals SUPN:US $ 133.68M 3.6M
Vertex Pharmaceuticals VRTX:US $ 1100.37M 171.23M
YTE INCY:US $ 516.69M 78.52M
Zogenix ZGNX:US $ 9.49M 1.78M